State NH
Clinical Trials in New Hampshire
Recruiting clinical trials with at least one study location in New Hampshire. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Hampshire
Frequently Asked Questions — Clinical Trials in New Hampshire
How many clinical trials are currently recruiting in New Hampshire?
ClinicalMetric currently tracks 38 actively recruiting clinical trials with at least one location in New Hampshire. The total number of registered studies—including active but not currently enrolling trials—is 38. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Hampshire?
New Hampshire hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Advanced Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Hampshire serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Hampshire?
To join a clinical trial in New Hampshire, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Hampshire maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Hampshire
NCT06215118 Phase 1
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab (PF-0686313...
Condition
Multiple Myeloma
Enrollment
87 pts
Location
United States, Australia, Canada
Sponsor
Pfizer
NCT05051033 N/A
Recruiting
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Yea...
Condition
Mitral Valve Regurgitation
Enrollment
450 pts
Location
United States, Canada, Germany
Sponsor
Annetine Gelijns
NCT06890338 Phase 2
Recruiting
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin ...
Condition
Epithelial Ovarian Cancer
Enrollment
140 pts
Location
United States
Sponsor
AbbVie
NCT05956158 N/A
Recruiting
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
Condition
Insomnia
Enrollment
83 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT07043270 Phase 2
Recruiting
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
Condition
Pancreas Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06581861 N/A
Recruiting
PREVENT ALL ALS Study
Condition
Amyotrophic Lateral Sclerosis
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
St. Joseph's Hospital and Medi
NCT06102486 N/A
Recruiting
MCI Speech in Noise
Condition
Mild Cognitive Impairment
Enrollment
70 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT07109505 N/A
Recruiting
Nutrition to Support Postoperative Recovery
Condition
Postoperative Care
Enrollment
100 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06429280 N/A
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Condition
Amblyopia
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
NCT06362369 Phase 1, Phase 2
Recruiting
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by ...
Condition
Advanced Cancer
Enrollment
126 pts
Location
United States
Sponsor
7 Hills Pharma, LLC
NCT07103356 N/A
Recruiting
Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hamps...
Condition
Arsenic Poisoning
Enrollment
20 pts
Location
United States
Sponsor
Trustees of Dartmouth College
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT02493478 N/A
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Condition
Failed or Difficult Intubation, Sequela
Enrollment
150,000 pts
Location
United States, Australia, Austria
Sponsor
Children's Hospital of Philade
NCT05304585 Phase 3
Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk an...
Condition
Embryonal Rhabdomyosarcoma
Enrollment
205 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05673148 Phase 3
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatme...
Condition
Metastatic Colorectal Adenocarcinoma
Enrollment
364 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
NCT06522568 N/A
Recruiting
Testing a Mammography Decision Intervention in a Rural Setting
Condition
Breast Cancer
Enrollment
39 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT06208150 Phase 3
Recruiting
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, a...
Condition
Multiple Myeloma
Enrollment
795 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT04889872 N/A
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAV...
Condition
Aortic Stenosis, Calcific
Enrollment
2,250 pts
Location
United States, Australia, Canada
Sponsor
Edwards Lifesciences
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT07228390 Phase 2
Recruiting
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults ...
Condition
Hidradenitis Suppurativa
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Pfizer
NCT07195513 N/A
Recruiting
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients Wit...
Condition
Palliative Care Referral
Enrollment
90 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT01790152 N/A
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopath...
Condition
Hodgkin Lymphoma in Remission
Enrollment
420 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
Page 1 of 2 — 38 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology